A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Nkarta, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,800,000 shares of NKTX stock, worth $22.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,800,000
Previous 3,450,000 10.14%
Holding current value
$22.5 Million
Previous $22.8 Million 80.4%
% of portfolio
0.08%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $1.96 Million - $5.5 Million
350,000 Added 10.14%
3,800,000 $41.1 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $4.34 Million - $21.9 Million
3,310,700 Added 2376.67%
3,450,000 $22.8 Million
Q2 2023

Aug 14, 2023

SELL
$2.19 - $5.17 $23,433 - $55,319
-10,700 Reduced 7.13%
139,300 $305,000
Q1 2023

May 15, 2023

BUY
$3.37 - $6.3 $505,500 - $945,000
150,000 New
150,000 $532,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $288M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.